This conference is the third in the series and will focus on cancer diagnostics. We will explore novel approaches to cancer diagnosis using various technologies such as liquid biopsies, imaging and digital pathology. Our regional strengths in these approaches will be showcased and we will consider how best to exploit these developments as we continue to build a world-leading diagnostics enterprise in the West Midlands.

As before, this event will bring together key stakeholders from across the NHS, academia, and industry to explore how we can enhance cross-sector collaboration to turbo-charge local growth by building the infrastructure necessary for the development and implementation of innovative diagnostics. With a focus on our distinctive expertise in diagnostics, we will consider how best to exploit these assets to create a sustainable and internationally-recognised activity in the West Midlands.